Human Vaccine Market Set to Expand by USD 29.1 Billion with 9.49% CAGR from 2023-2028, Drive by Innovations and Government Immunization Programs

Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Human Vaccine Market 2024-2028" report has been added to's offering.

The global human vaccine market is projected to experience significant growth over the next five years, driven by an acute awareness of vaccine preventatives and government-backed immunization initiatives. A recent study foresees an acceleration in the market would manifest in a compound annual growth rate (CAGR) of 9.49% between 2023 and 2028, resulting in an expanded market increase of USD 29.1 billion over the forecast period.

The most recent market analysis reflects a comprehensive understanding of current trends, growth drivers, and overarching market specifics. Factors propelling this growth include a burgeoning pediatric population, a pressing need for advanced vaccines targeting chronic infections, and elaborate public immunization programs sponsored by governments globally.

Market Segmentation Insights

The study scrutinizes the human vaccine market across different axes to render a detailed segmentation. It includes:

  • Route of Administration: Intramuscular, Subcutaneous, Oral
  • End-user Groups: Pediatrics, Adults
  • Geographical Reach: North America, Europe, Asia, Rest of World (ROW)

Trends and Opportunities in Vaccine Development

Research and development (R&D) of innovative vaccines are highlighted as a key market driver expected to boost the human vaccine industry within the coming years. Other significant trends include advancements in vaccine delivery systems and the emergence of nanoparticle vaccine technology, likely to instigate substantial industry demand.

Comprehensive Vendor Analysis

Market participants will find in the report a rich analysis of leading vendors that contribute to the global human vaccine landscape. These companies range from pharmaceutical giants to specialized biotechnology firms, each playing a strategic role in market dynamics.

The human vaccine market analysis offers critical data on both emerging and established trends and delivers an informed prognosis on market challenges and opportunities. Objective methodologies were employed in crafting this report, utilizing a mix of primary and secondary data collected from industry stakeholders, ensuring meticulous market predictions and vendor landscapes.

By identifying key market influencers and synthesizing an array of data sources, the report serves as an invaluable asset for companies aiming to consolidate their market position and capitalize on upcoming market developments.

The research purports to offer a strategic viewpoint for businesses seeking to navigate the proliferating market complexities and monetize the impending growth opportunities in the global human vaccine landscape.

Industry Analysis for Informed Decision-Making

To assist stakeholders in making informed decisions, the human vaccine market study encapsulates a diversified picture of the market, allowing for an analysis of key parameters such as profits, pricing, competitive environment, and promotion strategies. This compilation of comprehensive market research concludes with an in-depth competitive analysis, establishing a robust framework for market prediction accuracy.[element omitted: sales, customization, and delivery specifics are not to be mentioned as per the guidelines provided]

This publication will serve as a pivotal resource for entities engaged in the human vaccine industry, equipping them with the insights required to make strategic market decisions and harness anticipated growth trajectories within this dynamic sector.

A selection of companies mentioned in this report includes

  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • BioNTech SE
  • CanSino Biologics Inc.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Gradalis Inc.
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Mitsubishi Chemical Group Corp.
  • Moderna Inc.
  • Novavax Inc.
  • Pfizer Inc.
  • Serum Institute of India Pvt. Ltd.
  • Sanofi SA

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contact Data